Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

Luis Felipe Casado,1 Amparo Burgos,2 Eva González-Haba,3 Javier Loscertales,4 Tania Krivasi,5 Javier Orofino,6 Carlos Rubio-Terres,7 Darío Rubio-Rodríguez7 1Hematology Department, Hospital Virgen de la Salud, Toledo, Spain; 2Pharmacy Department, Hospital General Univ...

Full description

Bibliographic Details
Main Authors: Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
chlorambucil
chronic lymphocytic leukemia
cost-effectiveness
obinutuzumab
rituximab
Online Access:https://www.dovepress.com/economic-evaluation-of-obinutuzumab-in-combination-with-chlorambucil-i-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/economic-evaluation-of-obinutuzumab-in-combination-with-chlorambucil-i-peer-reviewed-article-CEOR

Similar Items